Editorial: Mycobacterial Glycolipids-Role in Immunomodulation and Targets for Vaccine Development
- PMID:33133110
- PMCID: PMC7579406
- DOI: 10.3389/fimmu.2020.603900
Editorial: Mycobacterial Glycolipids-Role in Immunomodulation and Targets for Vaccine Development
Keywords: Mycobacterium leprae; Mycobacterium tuberculosis; Mycobacterium ulcerans; glycolipid; immunomodulation; lipoarabinomannan; vaccine.
Comment on
- Editorial on the Research Topic Mycobacterial Glycolipids—Role in Immunomodulation and Targets for Vaccine Development
Similar articles
- Modern vaccines. Mycobacterial diseases.Fine PE, Rodrigues LC.Fine PE, et al.Lancet. 1990 Apr 28;335(8696):1016-20. doi: 10.1016/0140-6736(90)91074-k.Lancet. 1990.PMID:1970071Review.No abstract available.
- Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression.Guenin-Macé L, Siméone R, Demangel C.Guenin-Macé L, et al.Transbound Emerg Dis. 2009 Aug;56(6-7):255-68. doi: 10.1111/j.1865-1682.2009.01072.x. Epub 2009 May 26.Transbound Emerg Dis. 2009.PMID:19486312Review.
- Cell walls from Mycobacterium tuberculosis (BCG) as vaccine against Mycobacterium leprae infections in mice.Shepard CC, Ribi E.Shepard CC, et al.Proc Soc Exp Biol Med. 1968 Feb;127(2):517-21. doi: 10.3181/00379727-127-32729.Proc Soc Exp Biol Med. 1968.PMID:4967027No abstract available.
- Pathogenic and immunosuppressive properties of mycobacterial phenolic glycolipids.Oldenburg R, Demangel C.Oldenburg R, et al.Biochimie. 2017 Oct;141:3-8. doi: 10.1016/j.biochi.2017.03.012. Epub 2017 Mar 18.Biochimie. 2017.PMID:28322927Review.
- Glycopeptidolipids: immuno-modulators in greasy mycobacterial cell envelope.Mukherjee R, Chatterji D.Mukherjee R, et al.IUBMB Life. 2012 Mar;64(3):215-25. doi: 10.1002/iub.602. Epub 2012 Jan 18.IUBMB Life. 2012.PMID:22252955Review.
Cited by
- Reduction of hyperglycemia in STZ-induced diabetic mice by prophylactic treatment with heat-killedMycobacterium aurum: possible effects on glucose utilization, mitochondrial uncoupling, and oxidative stress in liver and skeletal muscle.Abdallah F, Bazzi S, Akle C, Bahr GM, Echtay KS.Abdallah F, et al.Front Endocrinol (Lausanne). 2024 Sep 6;15:1427058. doi: 10.3389/fendo.2024.1427058. eCollection 2024.Front Endocrinol (Lausanne). 2024.PMID:39377070Free PMC article.
- PGL-III, a Rare Intermediate ofMycobacterium leprae Phenolic Glycolipid Biosynthesis, Is a Potent Mincle Ligand.Ishizuka S, van Dijk JHM, Kawakita T, Miyamoto Y, Maeda Y, Goto M, Le Calvez G, Groot LM, Witte MD, Minnaard AJ, van der Marel GA, Ato M, Nagae M, Codée JDC, Yamasaki S.Ishizuka S, et al.ACS Cent Sci. 2023 Jul 12;9(7):1388-1399. doi: 10.1021/acscentsci.3c00040. eCollection 2023 Jul 26.ACS Cent Sci. 2023.PMID:37521780Free PMC article.
References
- WHO. World Health Organization Global Tuberculosis Report 2019. (World Health Organization; ) (2019). Available at:https://www.who.int/tb/publications/global_report/tb19_Exec_Sum_12Nov201....
- WHO. World Health Organization Global strategy and targets for tuberculosis prevention, care and control after 2015. (World Health Organization; ) (2014). Available at:https://www.who.int/tb/post_2015_tb_presentation.pdf.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical